Population pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese and nonobese patients-Reference-Cited by-同舟云学术

Population pharmacokinetics and pharmacodynamics of piperacillin and tazobactam administered by prolonged infusion in obese and nonobese patients

Published:2015-05-13 Issue:8 Volume:55 Page:899-908
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Chung Eun Kyoung¹,Cheatham S. Christian²,Fleming Megan R.³,Healy Daniel P.⁴,Shea Katherine M.⁵,Kays Michael B.⁶

Affiliation:

1. College of Pharmacy; Kyung Hee University; Seoul South Korea

2. Franciscan St. Francis Health; Department of Pharmacy; Indianapolis IN USA

3. Methodist Dallas Medical Center; Department of Pharmacy; Dallas TX USA

4. James L. Winkle College of Pharmacy, Division of Pharmacy Practice and Administrative Sciences; University of Cincinnati Academic Health Center; Cincinnati OH USA

5. Seton Healthcare Family; University Medical Center at Brackenridge, Department of Pharmacy; Austin TX USA

6. Purdue University College of Pharmacy; Indianapolis IN USA

Funder

Indiana Clinical and Translational Sciences Institute

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference40 articles.

1. 2012 http://www.who.int/mediacentre/factsheets/fs311/en

2. National regional, and global trends in adult overweight and obesity prevalences;Stevens;Popul Health Metr.,2012

3. Prevalence of childhood and adult obesity in the United States, 2011-2012;Ogden;JAMA.,2014

4. http://www.noo.org.uk/NOO_about_obesity/morbid_obesity

5. Dosing of antibiotics in obesity;Janson;CurrOpin Infect Dis.,2012

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combating bacterial resistance to Meropenem by infusion strategy applied to septic burn patients with vasopressor requirements or acute kidney injury to achieve the target;Pharmacy & Pharmacology International Journal;2024-05-22

2. Antimicrobial therapy in severe septic ICU major burn patients to combat bacterial resistance by pharmacokinetic-pharmacodymamics of vancomycin, meropenem, and piperacillin, cultures, and inflammatory biomarkers;Pharmacy & Pharmacology International Journal;2024-02-26

3. Antibiotic Therapy for Children With Obesity;2024 Nelson’s Pediatric Antimicrobial Therapy;2024-02-12

4. Patients with Obesity Should be Recognised as a Special Patient Population During Drug Development of Antibacterial and Antifungal Agents; A Call to Action;Clinical Pharmacokinetics;2024-01

5. Digital clinical decision support to improve pharmacotherapy in (morbidly) obese patients: a prospective intervention study.;2023-12-11